P-R-C You Later! GSA Previews Final Transition to Transactional Data Reporting for Schedule Contract Pricing
What You Need to Know
Key takeaway #1
Beginning in late June, Transactional Data Reporting will become mandatory for nearly all GSA Schedule contracts.
Key takeaway #2
At the same time, GSA’s longstanding Price Reductions Clause will be phased out, eliminating a significant source of historical liability.
Client Alert | 1 min read | 06.12.25
On June 9, 2025, the General Services Administration (GSA) Federal Acquisition Service (FAS) quietly announced that Transactional Data Reporting (TDR) would be exiting “pilot” status; under Refresh 27 to the Multiple Award Schedule (MAS), TDR will be mandatory for all eligible Special Item Numbers (SINs), effective beginning in the next sales reporting quarter after each contractor accepts the modification, with remaining SINs to be added in future refreshes.
GSA first launched the TDR pilot in 2016 to study potential replacements for legacy disclosure and reporting obligations to ensure the pricing offered to GSA customers is fair and reasonable. Those legacy obligations include the obligation to make Commercial Sales Practices (CSP) disclosures and to track commercial pricing and discounts to the negotiated Basis of Award customer under the Price Reductions Clause (PRC). Under TDR, Schedule contractors submit quarterly monthly reports capturing 16 data elements for all sales made under the Schedule, obviating the disclosure and price-tracking requirements of GSA’s legacy CSP/PRC regime.
While the TDR pilot received positive feedback from industry, it met resistance from GSA’s Office of the Inspector General, creating doubt over the program’s future. Nevertheless, FAS remained committed to the program, with Refresh 27 marking the culmination of efforts to make the Schedule program more accessible to industry.
Contacts
Insights
Client Alert | 4 min read | 09.16.26
CMS Offers Guidance as Scrutiny Rises Over ABA Therapy in Medicaid
Between 2021 and 2025, Medicaid spending on ABA therapy grew six times faster than the number of children who received services, making it one of the fastest-growing areas of Medicaid expenditure, according to CMS. On August 4, 2026, CMS released a toolkit to help state Medicaid and CHIP agencies strengthen their programs and limit fraud, waste, and abuse tied to increased demand for ABA therapy. In 2025, Medicaid spent about $10 billion on ABA and related therapy services for children with ASD — a dramatic increase from the $2 billion spent in 2021.
Client Alert | 4 min read | 09.15.26
GAO Indicates Reasonable Conflict of Interest Investigation Must Include Inquiry of Involved Firm
Client Alert | 3 min read | 09.15.26
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development



